Spero Therapeutics is a clinical-stage biopharmaceutical company advancing next-generation therapeutics in immunology and inflammation (I&I) to target the major upstream drivers of immune activation and control disease, while preserving protective immunity. We are led by an experienced team with a track record of advancing drug candidates from the clinic to registration. Development excellence, disciplined execution, and cross-functional collaboration are fundamental to our culture.